HIGHLIGHTS
- who: u042du0444u0444u0435u043au0442u0438u0432u043du043eu0441u0442u044c u043fu0440u0438u043cu0435u043du0435u043du0438u044f u043bu0443u043cu0430u043au0430u0444u0442u043eu0440u0430 / and colleagues from the Research Institute for Pulmonology of the Federal Medical Biological AgencyRussia Pirogov Russian National Research Medical University have published the paper: u041eu0440u0438u0433u0438u043du0430u043bu044cu043du0430u044f u0441u0442u0430u0442u044cu044f Original Article, in the Journal: (JOURNAL)
SUMMARY
Cystic fibrosis is a severe systemic multiorgan exocrinopathy, the severity of the condition in 95% cases is caused by the depth of respiratory organ damage. Keyword cystic fibrosis, lumacaftor/ivacaftor, respiratory function, nutritional status, targeted therapy, pathogenetic therapy For citation: Krasovskiy S.A. Kagazezhev R.U., Zonenko O.G., Sergienko D.F., Butyugina N.S., Gushchin . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.